Balshi Md Calming Hemp Seed For Eczema Relief
NDC Package 71070-968-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Balshi Md Calming Hemp Seed For Eczema Relief is a . Marketed by Balshi Md Dermaceuticals, this product is identified by NDC 71070-968 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
71070-968-03
Package Description
100 mL in 1 BOTTLE, PUMP
Product Code
71070-968
11-Digit Billing Format
71070096803

Clinical Specifications

Proprietary Name
Balshi Md Calming Hemp Seed For Eczema Relief
Dosage Form
-

Regulatory & Marketing

Labeler Name
Balshi Md Dermaceuticals
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-01-2019
End Marketing Date
09-23-2019
Listing Expiration
09-23-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71070-968-03 identifies a specific commercial package of 100 ml in 1 bottle, pump of Balshi Md Calming Hemp Seed For Eczema Relief, labeled by Balshi Md Dermaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Balshi Md Dermaceuticals on August 01, 2019. The current certification is valid through September 23, 2019.

How is this Balshi Md Dermaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71070096803. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71070-968-03
11-Digit CMS (5-4-2)
71070-0968-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.